Alpha Cognition (ACOG) Competitors $7.23 +0.25 (+3.58%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACOG vs. MNPR, SIGA, CMPS, MLTX, AQST, SVRA, NAGE, ZVRA, GOSS, and ETONShould you be buying Alpha Cognition stock or one of its competitors? The main competitors of Alpha Cognition include Monopar Therapeutics (MNPR), Siga Technologies (SIGA), COMPASS Pathways (CMPS), MoonLake Immunotherapeutics (MLTX), Aquestive Therapeutics (AQST), Savara (SVRA), Niagen Bioscience (NAGE), Zevra Therapeutics (ZVRA), Gossamer Bio (GOSS), and Eton Pharmaceuticals (ETON). These companies are all part of the "pharmaceutical products" industry. Alpha Cognition vs. Its Competitors Monopar Therapeutics Siga Technologies COMPASS Pathways MoonLake Immunotherapeutics Aquestive Therapeutics Savara Niagen Bioscience Zevra Therapeutics Gossamer Bio Eton Pharmaceuticals Alpha Cognition (NASDAQ:ACOG) and Monopar Therapeutics (NASDAQ:MNPR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings. Is ACOG or MNPR more profitable? Monopar Therapeutics' return on equity of -41.76% beat Alpha Cognition's return on equity.Company Net Margins Return on Equity Return on Assets Alpha CognitionN/A -80.16% -60.95% Monopar Therapeutics N/A -41.76%-39.49% Do insiders & institutionals have more ownership in ACOG or MNPR? 1.8% of Monopar Therapeutics shares are held by institutional investors. 14.0% of Alpha Cognition shares are held by insiders. Comparatively, 20.5% of Monopar Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has higher earnings and valuation, ACOG or MNPR? Alpha Cognition has higher revenue and earnings than Monopar Therapeutics. Monopar Therapeutics is trading at a lower price-to-earnings ratio than Alpha Cognition, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Cognition$4.59M32.95-$14.64M-$1.60-4.52Monopar TherapeuticsN/AN/A-$15.59M-$3.33-27.15 Which has more risk and volatility, ACOG or MNPR? Alpha Cognition has a beta of 2.63, meaning that its share price is 163% more volatile than the S&P 500. Comparatively, Monopar Therapeutics has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Do analysts recommend ACOG or MNPR? Alpha Cognition presently has a consensus target price of $20.00, suggesting a potential upside of 176.63%. Monopar Therapeutics has a consensus target price of $105.67, suggesting a potential upside of 16.86%. Given Alpha Cognition's higher probable upside, analysts plainly believe Alpha Cognition is more favorable than Monopar Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Cognition 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Monopar Therapeutics 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.00 Does the media favor ACOG or MNPR? In the previous week, Monopar Therapeutics had 14 more articles in the media than Alpha Cognition. MarketBeat recorded 17 mentions for Monopar Therapeutics and 3 mentions for Alpha Cognition. Alpha Cognition's average media sentiment score of 0.74 beat Monopar Therapeutics' score of 0.52 indicating that Alpha Cognition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Cognition 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Monopar Therapeutics 3 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAlpha Cognition and Monopar Therapeutics tied by winning 7 of the 14 factors compared between the two stocks. Get Alpha Cognition News Delivered to You Automatically Sign up to receive the latest news and ratings for ACOG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACOG vs. The Competition Export to ExcelMetricAlpha CognitionMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$151.12M$3.39B$6.04B$10.49BDividend YieldN/A2.30%5.73%4.80%P/E Ratio-4.5222.9085.1927.32Price / Sales32.95269.18516.16194.55Price / CashN/A46.9537.5761.53Price / Book2.7910.5312.426.81Net Income-$14.64M-$52.58M$3.32B$276.59M7 Day Performance-6.35%1.06%0.80%0.15%1 Month Performance-23.49%16.05%10.52%8.17%1 Year PerformanceN/A18.41%76.14%35.50% Alpha Cognition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACOGAlpha Cognition2.9572 of 5 stars$7.23+3.6%$20.00+176.6%N/A$151.12M$4.59M-4.52N/AMNPRMonopar Therapeutics2.5044 of 5 stars$98.52-1.0%$97.33-1.2%+1,667.9%$607.87MN/A-29.5910Analyst ForecastSIGASiga Technologies1.7409 of 5 stars$8.44+2.6%N/A+21.3%$604.39M$138.72M7.4740CMPSCOMPASS Pathways3.2248 of 5 stars$6.24-0.8%$16.29+161.0%+11.8%$598.67MN/A-3.39120News CoverageAnalyst ForecastGap UpMLTXMoonLake Immunotherapeutics2.8852 of 5 stars$9.28+7.2%$36.00+287.9%-79.3%$596.05MN/A-3.342High Trading VolumeAQSTAquestive Therapeutics2.7732 of 5 stars$5.97flat$10.29+72.3%+42.1%$595.35M$44.13M-8.53160SVRASavara3.0276 of 5 stars$3.43-0.9%$7.50+118.7%-7.7%$592.83MN/A-6.8620Analyst UpgradeNAGENiagen Bioscience3.071 of 5 stars$7.18-1.1%$13.42+86.9%N/A$572.63M$116.30M34.19120ZVRAZevra Therapeutics2.6092 of 5 stars$10.19-4.3%$24.00+135.5%+29.8%$572.02M$62.02M-48.5220Analyst UpgradeHigh Trading VolumeGOSSGossamer Bio3.8351 of 5 stars$2.50+3.7%$8.50+240.0%+152.7%$568.45M$40.24M-4.03180Gap UpETONEton Pharmaceuticals2.6748 of 5 stars$21.15+2.0%$29.67+40.3%+129.2%$567.20M$58.18M-132.1920 Related Companies and Tools Related Companies MNPR Competitors SIGA Competitors CMPS Competitors MLTX Competitors AQST Competitors SVRA Competitors NAGE Competitors ZVRA Competitors GOSS Competitors ETON Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACOG) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Cognition Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Cognition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
